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Breast milk is the normal way to feed infants and is accepted worldwide as the optimal first source of nutrition.
Though the majority intend to breastfeed, many mothers of sick, hospitalized newborns, particularly those of very
low birth weight, are unable to provide a full volume of milk due to numerous physical and emotional barriers to
breastfeeding. This vulnerable population of infants may benefit most from receiving breast milk nutrition and thus
pasteurized donor milk should be the first consideration for supplementation when there is an inadequate supply
of mother’s own milk. This commentary will briefly review the history of milk banking in Canada, as well as the best
available evidence for donor milk use in the very low birth weight population, including available economic
analyses, with a view to advocate for its use in these vulnerable infants.
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Breast milk is the normal way to feed infants and is ac-
cepted worldwide as the optimal exclusive first source of
nutrition [1-5]. The overwhelming majority of Canadian
mothers wish to breastfeed. For mothers of vulnerable in-
fants, however, particularly those of very low birth weight
(VLBW, <1500 g) or requiring gastrointestinal surgery, it
is more than simply a matter of desire. Despite their best
intentions, only a minority can produce a full volume of
milk due to numerous physical and emotional barriers to
breastfeeding, including maternal illness, stress, immature
lactocytes, and separation from their infant. In our neo-
natal intensive care unit (NICU), the largest in Canada,
only 30% of mothers are able to achieve exclusive breast-
feeding. Until very recently, preterm formula was offered
in most Canadian NICUs as a standard supplement in the
absence of mother’s own milk. It is in this vulnerable
population of infants, however, that the benefits of breast
milk may be most important. Our first priority must be to
support mothers in the provision of their own milk and
our second priority should be to have donor milk rou-
tinely available as a safe, efficacious and cost-effective* Correspondence: sklee@mtsinai.on.ca
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unless otherwise stated.supplement when it is not possible to give mother’s own
milk [6].Discussion
The Canadian Paediatric Society and the American Acad-
emy of Pediatrics have recommended fortified breast
milk as first-line nutrition for preterm and other high-risk
infants since the mid to late 1990s [7,8]. The benefits of
breast milk compared with formula in VLBW infants are
well established. Preterm infants fed breast milk display
improved feeding tolerance [9], develop fewer severe infec-
tions [10,11] and fewer episodes of necrotizing enterocolitis
(NEC) [12], are less colonized by pathogenic organisms
[13,14], and experience decreased lengths of hospital stay
[15] and reduced rates of hospital re-admission after
discharge [16]. Importantly, breast milk-fed preterm infants
also have improved neurodevelopmental outcomes. A
meta-analysis by Anderson et al. showed a significant in-
crease in measures of cognitive function among breastfed
infants compared with their formula-fed counterparts [17].
The effect of breast milk was greatest for LBW infants, and
held true after adjusting for possible socioeconomic con-
founders. A recent large-scale observational study by Vohr
et al. assessing early nutrition of extremely LBW infants
found a dose-dependent response to breast milk exposure
on cognitive outcome as assessed by the Bayley Mental
Developmental Index at 18 months of age [18]; this effectl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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cognitive outcomes is likely multifactorial: breast milk pro-
motes optimal feeding tolerance, provides an optimum
substrate for brain and somatic growth, and provides
protection against many complications associated with
preterm birth that may negatively impact neurodevelop-
ment [9-12,15].
The first human milk bank opened in Vienna, Austria
in 1909 and the first in North America opened in 1919
in Boston, USA [19,20]. Banks continued to be estab-
lished until the emergence of the HIV epidemic in the
mid 1980s when many closed their doors in response to
uncertainty of disease transmission via donor milk. With
advances in donor screening and infectious disease
testing assuring its safety, as well as mounting evidence
for the benefit of breast milk in general, interest and
demand has increased exponentially for donor milk.Figure 1 Processing donor milk at the Rogers Hixon Ontario Human M
processed, and redistributed through the Rogers Hixon Ontario Human Mil
8 months since it opened.Currently there are 13 non-profit donor milk banks in
North America. In addition to a long-standing bank in
Vancouver, Canada now has a second operational bank
in Calgary, a third in Ontario (see Figure 1), and one in
development in Quebec [20]. In Canada, donor milk has
been advocated for by the Canadian Paediatric Society
[6]. It is regulated by Health Canada under food guide-
lines and all banks follow donor screening protocols
established by the Canadian Blood Services. Donor milk
has been widely accepted as shown by the example in
Ontario, Canada’s largest province, where all tertiary care
NICUs began importing donor milk within 6 months of
the opening of the provincial milk bank. All Canadian
banks are members of the Human Milk Banking Associ-
ation of North America (HMBANA), whose policies guide
the processing of human milk. The amount of milk dis-
pensed by HMBANA banks rose from 409,077 ounces inilk Bank. Donor milk is collected from across Ontario, Canada,
k Bank. The milk bank dispensed 18,000 ounces of milk in the first
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400% increase [20].
In North America, donor milk is pasteurized according
to the Holder technique (see Figure 2) which, in com-
bination with at least one additional container change
and freeze/thaw cycle, can affect nutrient composition.
This issue can be addressed by nutrient fortification of
milk as required. However, pasteurization is known to
have a greater impact on some of the bioactive compo-
nents in milk [21]. For this reason, the efficacy of donor
milk must be considered separately from mother’s own
milk when reviewing the literature. The majority of
donor milk research was generated prior to 1985 when
many milk banks closed. The best evidence for its effi-
cacy is a Cochrane review by Quigley et al. [22]. This
meta-analysis included 8 randomized controlled trials
that compared formula feeding versus human donor
milk in preterm infants and found higher rates of diar-
rhea and feeding intolerance among formula-fed infants,
and more importantly, significantly higher rates of NEC.
The review did not show an effect on long-term growth
or development, although those infants fed formula dis-
played higher short-term rates of growth. The latter
finding is not unexpected, as only one trial used
nutrient-fortified donor milk—a practice that is now
standard [7,8]. All but one trial were also over 20 years
old, conducted at a time when morbidity and mortality
for VLBW infants were far greater and feeding practices
did not reflect preferential use of breast milk.
It is reasonable to expect that if similar trials were
conducted today, infants fed fortified donor milk would
not only experience improved growth, but many of the
other beneficial effects of breast milk as well. One recentFigure 2 Pasteurization of donor milk. In North America, donor
milk is pasteurized according to the Holder technique, which
involves heating the milk to 62.5°C/144.5 °F and holding this
for 30 minutes.industry-sponsored trial demonstrated that an exclusively
human milk-based diet, including human milk-based hu-
man milk fortifier (HMF) and donor milk, resulted in a
significant reduction in medical and surgical NEC in
extremely preterm infants compared with those supple-
mented with bovine-based products [23]. At present, there
are two multi-centre randomized control trials underway
whose aim is to assess the impact of receiving donor
breast milk as compared with preterm formula when
mother’s milk is not available for very low birth weight in-
fants: the American Milk Trial [24] and the Canadian
Donor Milk for Improved Neurodevelopmental Outcomes
Trial [25]. These are both large-scale trials, reflective of
current era feeding practices in the most vulnerable in-
fants, and have a primary outcome of long-term neurode-
velopment as assessed by the Bayley Scales of Infant
Development at 18 months corrected age.
There are also financial considerations in the use of
donor breast milk. Operating a milk bank, including
donor testing as well as processing, testing, and shipping
donor milk entails a cost. However, in comparison with
the cost of medical or surgical management of even one
case of NEC or a resulting case of short bowel syn-
drome, this cost is nominal. Though there have been no
Canadian analyses of the potential economic impact of
donor milk, a Californian study estimated a cost savings
to the healthcare system of $11 for every $1 spent on
donor milk as a result of the reduction in hospital stay,
NEC and sepsis associated with its use [26]. A recent
study evaluating the cost-effectiveness of a 100% human
milk-based diet including human milk-based fortifier for
extremely preterm infants compared with bovine-based
fortifier estimated a net savings of 3.9 NICU days and
$8,167.17 per infant in preventable costs for NEC [27].
Conclusion
Optimizing nutrition for preterm infants is of critical im-
portance in promoting their health and improving their
long term neurodevelopmental outcome. We must there-
fore advocate for improved supports enabling mothers to
provide their own milk for their infant, as well as advocate
for donor milk banking as the superior alternative in the
absence of mother’s own milk.
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